BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 9596916)

  • 1. [Comparison of two techniques used in immediate postplacental insertion of TCu 380A intrauterine device: 12 month follow-up of 910 cases].
    Xu J; Zhuang L; Yu G
    Zhonghua Fu Chan Ke Za Zhi; 1997 Jun; 32(6):354-7. PubMed ID: 9596916
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparative study of two techniques used in immediate postplacental insertion (IPPI) of the Copper T-380A IUD in Shanghai, People's Republic of China.
    Xu JX; Rivera R; Dunson TR; Zhuang LQ; Yang XL; Ma GT; Chi IC
    Contraception; 1996 Jul; 54(1):33-8. PubMed ID: 8804806
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Performances of copper T 380A and multiload copper 375/250 intrauterine contraceptive devices in a comparative clinical trial.
    Arowojolu AO; Otolorin EO; Ladipo OA
    Afr J Med Med Sci; 1995 Mar; 24(1):59-65. PubMed ID: 7495202
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Random comparative study between intrauterine device Multiload Cu375 and TCu 380a inserted in the postpartum period].
    Lara Ricalde R; Menocal Tobías G; Ramos Pérez C; Velázquez Ramírez N
    Ginecol Obstet Mex; 2006 Jun; 74(6):306-11. PubMed ID: 16970116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison between two techniques used in immediate postplacental insertion of TCu 380A intrauterine device: 36-month follow-up.
    Xu J; Yang X; Gu X; Xu S; Zhou X; Chen Y; Xiao Z; Zhuang L
    Reprod Contracept; 1999; 10(3):156-62. PubMed ID: 12349462
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical outcomes of early postplacental insertion of intrauterine contraceptive devices.
    Celen S; Möröy P; Sucak A; Aktulay A; Danişman N
    Contraception; 2004 Apr; 69(4):279-82. PubMed ID: 15033401
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of efficacy and complications of IUD insertion in immediate postplacental/early postpartum period with interval period: 1 year follow-up.
    Eroğlu K; Akkuzu G; Vural G; Dilbaz B; Akin A; Taşkin L; Haberal A
    Contraception; 2006 Nov; 74(5):376-81. PubMed ID: 17046378
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Randomized comparative study of GyneFix IN and TCu 380A intrauterine devices].
    Wu S; Hu J; Wu M
    Zhonghua Fu Chan Ke Za Zhi; 1998 Jun; 33(6):345-8. PubMed ID: 10806672
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TCu 380A IUD: a reversible permanent contraceptive method in women over 35 years of age.
    Bahamondes L; Faundes A; Sobreira-Lima B; Lui-Filho JF; Pecci P; Matera S
    Contraception; 2005 Nov; 72(5):337-41. PubMed ID: 16246658
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Use of modified intrauterine device (IUD) TCu 380 with chromium filaments in the immediate postpartum].
    Hernández Valencia M; Becerril Flores LC
    Ginecol Obstet Mex; 2000 Feb; 68():70-6. PubMed ID: 10774108
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immediate postplacental insertion of an intrauterine contraceptive device during cesarean section.
    Çelen Ş; Sucak A; Yıldız Y; Danışman N
    Contraception; 2011 Sep; 84(3):240-3. PubMed ID: 21843687
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of the delta copper T and the copper T 200 in Bologna, Italy.
    Melega C; Biscontin S; Canedi L; Marchesini FP; Tirelli S; Bartolotti T; Flamigni C
    Acta Eur Fertil; 1986; 17(1):39-41. PubMed ID: 3727892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The comparative trial of TCu 380A IUD and progesterone-releasing vaginal ring used by lactating women.
    Chen JH; Wu SC; Shao WQ; Zou MH; Hu J; Cong L; Miao L; Wang C; Dong J; Gao J; Xiao BL
    Contraception; 1998 Jun; 57(6):371-9. PubMed ID: 9693396
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Postpartum IUDS: keys for success.
    O'Hanley K; Huber DH
    Contraception; 1992 Apr; 45(4):351-61. PubMed ID: 1516367
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intrauterine devices: an effective alternative to oral hormonal contraception.
    Prescrire Int; 2009 Jun; 18(101):125-30. PubMed ID: 19637436
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interactions between intrauterine contraceptive device use and breast-feeding status at time of intrauterine contraceptive device insertion: analysis of TCu-380A acceptors in developing countries.
    Farr G; Rivera R
    Am J Obstet Gynecol; 1992 Jul; 167(1):144-51. PubMed ID: 1442918
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Study of side-effects of Cu-T as intra-uterine contraceptive device in post medical termination of pregnancy and interval cases.
    Das CR; Pradhan G
    J Indian Med Assoc; 1995 Oct; 93(10):375-6. PubMed ID: 9053409
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Dalkon Shield, the TCu 200, and the TCu 380A in private practice.
    Thomas WO
    Trans Pac Coast Obstet Gynecol Soc; 1977; 44():78-85. PubMed ID: 335580
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical performance of the TCu 380A and Lippes Loop IUDs in three developing countries.
    Farr G; Amatya R; Acosta M; Ekwempu C; Kisninci H
    Contraception; 1995 Jul; 52(1):17-22. PubMed ID: 8521710
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immediate postplacental insertion of GYNE-T 380 and GYNE-T 380 postpartum intrauterine contraceptive devices: randomized study.
    Tatum HJ; Beltran RS; Ramos R; Van Kets H; Sivin I; Schmidt FH
    Am J Obstet Gynecol; 1996 Nov; 175(5):1231-5. PubMed ID: 8942493
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.